These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 39113260

  • 1. Total mesorectal excision quality in rectal cancer surgery affects local recurrence rate but not distant recurrence and survival: population-based cohort study.
    Collin Å, Dahlbäck C, Folkesson J, Buchwald P.
    BJS Open; 2024 Jul 02; 8(4):. PubMed ID: 39113260
    [Abstract] [Full Text] [Related]

  • 2. Association of Plane of Total Mesorectal Excision With Prognosis of Rectal Cancer: Secondary Analysis of the CAO/ARO/AIO-04 Phase 3 Randomized Clinical Trial.
    Kitz J, Fokas E, Beissbarth T, Ströbel P, Wittekind C, Hartmann A, Rüschoff J, Papadopoulos T, Rösler E, Ortloff-Kittredge P, Kania U, Schlitt H, Link KH, Bechstein W, Raab HR, Staib L, Germer CT, Liersch T, Sauer R, Rödel C, Ghadimi M, Hohenberger W, German Rectal Cancer Study Group.
    JAMA Surg; 2018 Aug 01; 153(8):e181607. PubMed ID: 29874375
    [Abstract] [Full Text] [Related]

  • 3. Review of the quality of total mesorectal excision does not improve the prediction of outcome.
    Demetter P, Jouret-Mourin A, Silversmit G, Vandendael T, Sempoux C, Hoorens A, Nagy N, Cuvelier C, Van Damme N, Penninckx F, PROCARE.
    Colorectal Dis; 2016 Sep 01; 18(9):883-8. PubMed ID: 27586703
    [Abstract] [Full Text] [Related]

  • 4. Early Experience With Transanal Total Mesorectal Excision Compared With Laparoscopic Total Mesorectal Excision for Rectal Cancer: A Propensity Score-Matched Analysis.
    Alhanafy MK, Park SS, Park SC, Park B, Kim MJ, Sohn DK, Chang HJ, Oh JH.
    Dis Colon Rectum; 2020 Nov 01; 63(11):1500-1510. PubMed ID: 33044291
    [Abstract] [Full Text] [Related]

  • 5. Effect of the plane of surgery achieved on local recurrence in patients with operable rectal cancer: a prospective study using data from the MRC CR07 and NCIC-CTG CO16 randomised clinical trial.
    Quirke P, Steele R, Monson J, Grieve R, Khanna S, Couture J, O'Callaghan C, Myint AS, Bessell E, Thompson LC, Parmar M, Stephens RJ, Sebag-Montefiore D, MRC CR07/NCIC-CTG CO16 Trial Investigators, NCRI Colorectal Cancer Study Group.
    Lancet; 2009 Mar 07; 373(9666):821-8. PubMed ID: 19269520
    [Abstract] [Full Text] [Related]

  • 6. Anterior resection for rectal cancer with mesorectal excision: a prospective evaluation of 622 patients.
    Law WL, Chu KW.
    Ann Surg; 2004 Aug 07; 240(2):260-8. PubMed ID: 15273550
    [Abstract] [Full Text] [Related]

  • 7. Organ preservation with chemoradiotherapy plus local excision for rectal cancer: 5-year results of the GRECCAR 2 randomised trial.
    Rullier E, Vendrely V, Asselineau J, Rouanet P, Tuech JJ, Valverde A, de Chaisemartin C, Rivoire M, Trilling B, Jafari M, Portier G, Meunier B, Sieleznieff I, Bertrand M, Marchal F, Dubois A, Pocard M, Rullier A, Smith D, Frulio N, Frison E, Denost Q.
    Lancet Gastroenterol Hepatol; 2020 May 07; 5(5):465-474. PubMed ID: 32043980
    [Abstract] [Full Text] [Related]

  • 8. [Safety and prognosis analysis of transanal total mesorectal excision versus laparoscopic mesorectal excision for mid-low rectal cancer].
    Sun R, Cong L, Qiu HZ, Lin GL, Wu B, Niu BZ, Sun XY, Zhou JL, Xu L, Lu JY, Xiao Y.
    Zhonghua Wei Chang Wai Ke Za Zhi; 2022 Jun 25; 25(6):522-530. PubMed ID: 35754217
    [Abstract] [Full Text] [Related]

  • 9. Oncological outcomes after total mesorectal excision for cure for cancer of the lower rectum: anterior vs. abdominoperineal resection.
    Wibe A, Syse A, Andersen E, Tretli S, Myrvold HE, Søreide O, Norwegian Rectal Cancer Group.
    Dis Colon Rectum; 2004 Jan 25; 47(1):48-58. PubMed ID: 14719151
    [Abstract] [Full Text] [Related]

  • 10. Impact of rectal perforation on recurrence during rectal cancer surgery in a national population registry.
    Jörgren F, Lydrup ML, Buchwald P.
    Br J Surg; 2020 Dec 25; 107(13):1818-1825. PubMed ID: 32484249
    [Abstract] [Full Text] [Related]

  • 11. Total mesorectal excision in MRI-defined low rectal cancer: multicentre study comparing oncological outcomes of robotic, laparoscopic and transanal total mesorectal excision in high-volume centres.
    Rutgers ML, Burghgraef TA, Hol JC, Crolla RM, van Geloven NA, Leijtens JW, Polat F, Pronk A, Smits AB, Tuyman JB, Verdaasdonk EG, Sietses C, Consten EC, Hompes R.
    BJS Open; 2024 May 08; 8(3):. PubMed ID: 38788679
    [Abstract] [Full Text] [Related]

  • 12. Completion Surgery in Unfavorable Rectal Cancer after Transanal Endoscopic Microsurgery: Does It Achieve Satisfactory Sphincter Preservation, Quality of Total Mesorectal Excision Specimen, and Long-term Oncological Outcomes?
    Serra-Aracil X, Galvez Saldaña A, Mora-Lopez LL, Montes N, Pallisera-Lloveras A, Serra-Pla S, Pericay C, Navarro-Soto S.
    Dis Colon Rectum; 2021 Feb 01; 64(2):200-208. PubMed ID: 33315715
    [Abstract] [Full Text] [Related]

  • 13. Long-term prognostic value of mesorectal grading after neoadjuvant chemoradiotherapy for rectal cancer.
    Madbouly KM, Hussein AM, Abdelzaher E.
    Am J Surg; 2014 Sep 01; 208(3):332-41. PubMed ID: 24581995
    [Abstract] [Full Text] [Related]

  • 14. T3N0 rectal cancer: results following sharp mesorectal excision and no adjuvant therapy.
    Merchant NB, Guillem JG, Paty PB, Enker WE, Minsky BD, Quan SH, Wong D, Cohen AM.
    J Gastrointest Surg; 1999 Sep 01; 3(6):642-7. PubMed ID: 10554372
    [Abstract] [Full Text] [Related]

  • 15. A national strategic change in treatment policy for rectal cancer--implementation of total mesorectal excision as routine treatment in Norway. A national audit.
    Wibe A, Møller B, Norstein J, Carlsen E, Wiig JN, Heald RJ, Langmark F, Myrvold HE, Søreide O, Norwegian Rectal Cancer Group.
    Dis Colon Rectum; 2002 Jul 01; 45(7):857-66. PubMed ID: 12130870
    [Abstract] [Full Text] [Related]

  • 16. The relationship between mesorectal grading and oncological outcome in rectal adenocarcinoma.
    Silva-Velazco J, Stocchi L, Valente MA, Church JM, Liska D, Gorgun E, Kalady MF, Kessler H, Steele SR, Delaney CP.
    Colorectal Dis; 2019 Mar 01; 21(3):315-325. PubMed ID: 30565830
    [Abstract] [Full Text] [Related]

  • 17. Association of Surgical Approaches and Outcomes in Total Mesorectal Excision and Margin Status for Rectal Cancer.
    Mirza MB, Gamboa AC, Irlmeier R, Hopkins B, Regenbogen SE, Hrebinko KA, Holder-Murray J, Wiseman JT, Ejaz A, Wise PE, Ye F, Idrees K, Hawkins AT, Balch GC, Khan A.
    J Surg Res; 2024 Aug 01; 300():494-502. PubMed ID: 38875948
    [Abstract] [Full Text] [Related]

  • 18. Oncological outcome following Hartmann's procedure compared with anterior resection and abdominoperineal resection for rectal cancer-The type of procedure does not influence local recurrence or distant metastasis: A population-based study.
    Mariusdottir E, Jörgren F, Lydrup ML, Buchwald P.
    Colorectal Dis; 2024 Oct 01; 26(10):1822-1830. PubMed ID: 39245864
    [Abstract] [Full Text] [Related]

  • 19. Factors that influence the adequacy of total mesorectal excision for rectal cancer.
    Jeyarajah S, Sutton CD, Miller AS, Hemingway D, Leicester Colorectal Specialist Group.
    Colorectal Dis; 2007 Nov 01; 9(9):808-15. PubMed ID: 17441969
    [Abstract] [Full Text] [Related]

  • 20. Robotic versus laparoscopic surgery for middle and low rectal cancer (REAL): short-term outcomes of a multicentre randomised controlled trial.
    Feng Q, Yuan W, Li T, Tang B, Jia B, Zhou Y, Zhang W, Zhao R, Zhang C, Cheng L, Zhang X, Liang F, He G, Wei Y, Xu J, REAL Study Group.
    Lancet Gastroenterol Hepatol; 2022 Nov 01; 7(11):991-1004. PubMed ID: 36087608
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.